Measuring Regulatory/Quality Team Member Performance
Jun 3, 2026 - 62:20
Radio and PodcastLive Radio & PodcastsHealth
You Got a 483 from the FDA. Now what?
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences , we’re discussing what the process should be for a company once they receive a 483 or warning letter from the FD...
About This Episode
You Got a 483 from the FDA. Now what? is an episode from Medtech Matters by Medical Product Outsourcing. In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences , we’re discussing what the...
Podcast
This episode belongs to Medtech Matters.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Aug 22, 2024, 60:15 long, audio available.
Related Episodes
Continue listening to more episodes from Medtech Matters.
FDA's Third-Party Review Program
May 14, 2026 - 61:00
Triaging Your QMS: Considerations Based on the New QMSR
Apr 17, 2026 - 59:19
A Deep Dive into E&L and Biocomp Testing
Mar 11, 2026 - 22:09
Planning for FDA Shutdowns Now and in the Future
Oct 27, 2025 - 57:28
Should Wellness Products Come with a Warning?
Sep 11, 2025 - 66:02
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees
Jun 25, 2025 - 53:16
Why Are One-Third of MAUDE Reports a Problem?
Jun 10, 2025 - 58:10